Brand-name drug
Qelbree price, strengths & recalls
Brand of viloxazine (generic)
Pharmacies pay $381.87 for 30 capsules of Qelbree 200 mg (24 hr) extended-release capsule this week, and from $381.77 to $381.94 across its 3 priced strengths and forms. Its official label last changed on October 8, 2026.
Brand- Fair cash price
- $449.65
- Strengths
- 3
- Makers
- 1
- Updated
- Nov 11
Qelbree price by strength
What pharmacies pay for each strength and form this week (Nov 11, 2026), for the usual package. Choose one for its fair price, 52-week chart and makers.
| Strength and form | Per unit | Pharmacies pay |
|---|---|---|
| 100 mg (24 hr) extended-release capsule Brand | $12.73 | $381.94 / 30 capsules |
| 150 mg (24 hr) extended-release capsule Brand | $12.73 | $381.77 / 30 capsules |
| 200 mg (24 hr) extended-release capsule Brand | $12.73 | $381.87 / 30 capsules |
The lowest cost per capsule is 150 mg (24 hr) extended-release capsule at $12.73. Strengths aren't interchangeable - ask your pharmacist or prescriber before changing.
Qelbree vs generic viloxazine
There is no generic version of Qelbree on the market yet. Its last listed patent or exclusivity runs to April 2, 2035 - generics often follow, though court cases and settlements can move the date either way.
GenericViloxazine pricesSupply status: shortages & recalls
What people paid for Qelbree
Bought it recently? Share the price, the pharmacy and how you paid - it's the most useful thing the next person can read.
Official label & what changed
These highlights do not include all the information needed to use QELBREE ® safely and effectively. See full prescribing information for QELBREE ®. QELBREE ® (viloxazine extended-release capsules), for oral use Initial U.S. Approval: 2021
WARNING: SUICIDAL THOUGHTS AND BEHAVIORS
In clinical studies, higher rates of suicidal thoughts and behavior were reported in patients with ADHD treated with Qelbree than in patients treated with placebo.
Closely monitor all Qelbree-treated patients for clinical worsening, and for emergence of suicidal thoughts and behaviors
[see
Warnings and Precautions (5.1)]
.
WARNING: SUICIDAL THOUGHTS AND BEHAVIORS
See full prescribing information for complete boxed warning.
In clinical trials, higher rates of suicidal thoughts and behavior were reported in patients treated with Qelbree than in patients treated with placebo. Closely monitor for worsening and emergence of suicidal thoughts and behaviors (
5.1).
We check this label every day. When it changes, the sections that changed appear here, old text beside new.
We show the official text and what changed; we don't interpret it. Ask your pharmacist or prescriber what a change means for you.
Approval, patents & generics
- Application
- NDA211964 · Supernus Pharms
- First approved
- April 2, 2021 (5 years ago)
- Latest approved change
- January 23, 2025
- Approved label
- PDF, Feb 6, 2025
- Generic makers
- None on the market
- Last patent listed
- April 2, 2035
- Exclusivity ends
- April 2, 2026 (ended)
Patent dates are what the maker lists with FDA. Generic launch dates are often set by court rulings or settlements instead. Upcoming generics.
Qelbree questions
How much does qelbree cost without insurance?
Pharmacies pay about $381.87 for 30 capsules of qelbree 200 mg (24 hr) extended-release capsule ($12.73 per capsule). A fair cash price - that cost plus a 15% margin and a typical dispensing fee - is about $449.65. If you're quoted much more, check your quote and ask for the pharmacy's cash price.
Is there a generic for Qelbree?
Yes: viloxazine. Compare viloxazine prices.
Is qelbree in shortage?
No shortage is reported for qelbree right now. We check the national shortage list every day.
Has qelbree been recalled?
No recalls are on record for qelbree.
When did the qelbree label last change?
The official label was last updated on October 8, 2026 (version 16). See what changed.
Talk about qelbree
No comments yet. Questions, tips, what worked for you - start the conversation.